This is a purely administrative segment realignment filing. No trading action is warranted. Monitor the next quarterly report for any operational or financial impact from the new structure.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 29 $71.90entry
- T+1 · 4mo ago −2.73%α −4.40% · $69.94
- T+5 · 3mo ago −2.31%α −7.84% · $70.24
- T+20 · 3mo ago +1.96%α −3.06% · $73.31
- T+60 · 26d ago −0.67%α −5.40% · $71.42
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
GE HealthCare filed an 8-K to disclose a change in its reportable segment structure, combining Imaging and Advanced Visualization Solutions into a new Advanced Imaging Solutions (AIS) segment. The filing includes recast unaudited historical financials for comparability but does not report any new financial results or guidance for the current period. This is a routine organizational realignment with no immediate financial impact.
Key Facts
- GE HealthCare combined its Imaging and Advanced Visualization Solutions businesses into a new segment, Advanced Imaging Solutions (AIS), in Q2 2026.
- The company now operates three reportable segments: AIS, Pharmaceutical Diagnostics (PDx), and Patient Care Solutions (PCS).
- Recast unaudited historical financials were provided for Q1 2026, FY2025, FY2024, and quarterly periods within those years.
- Total revenues for Q1 2026 were $5,131 million, compared to $4,777 million in Q1 2025.
- Organic revenue growth for total company was 2.9% in Q1 2026.
- Segment EBIT for AIS was $479 million, PDx $197 million, and PCS $10 million in Q1 2026.
- The filing does not contain any new earnings results, guidance updates, or material financial events.
Financial Impact
No new financial impact; recast data is for comparability only.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001932393-26-000047 |
| Document: gehc-20260729.htm | 0001932393-26-000047 |
| Document: 0001932393-26-000047-index-headers.html | 0001932393-26-000047 |
| Document: 0001932393-26-000047-index.html | 0001932393-26-000047 |
| Document: 0001932393-26-000047.txt | 0001932393-26-000047 |
Track record
13 reports on GEHC
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +19.07% at T+20 after the Oct 19, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Neutral 3/10 Entry $83.75 to $81.84 Now $82.96 −0.94% ▼ −2.28% −5.57% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $83.75 to $81.84 Now $82.96 −0.94% ▼ −2.28% −5.57% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $75.82 to $85.81 Now $82.96 +9.42% ▲ +13.18% +13.89% vs SPY
- Oct 19, 202628d ago Institutional Cluster Bullish 4/10 Entry $69.72 to $71.60 Now $82.96 +18.99% ▲ +2.70% +2.84% vs SPY
- Sep 22, 20267w ago 8-K Neutral 2/10 Entry $66.09 to $65.37 Now $82.96 +25.53% ▼ −1.09% −0.41% vs SPY
- Sep 16, 20268w ago 3 Neutral 2/10 Entry $64.45 to $66.38 Now $82.96 +28.73% ▲ +3.00% +2.40% vs SPY
- Jul 29, 202615w ago 8-K Neutral 2/10 Viewing Entry $71.90 to $70.24 Now $82.96 +15.38% ▼ −2.31% −7.84% vs SPY
- May 13, 202626w ago Insider Cluster Neutral 2/10 Entry $64.26 to $62.86 Now $82.96 +29.10% ▼ −2.18% −3.98% vs SPY
- May 11, 202627w ago 8-K Neutral 2/10 Entry $62.29 to $61.51 Now $82.96 +33.18% ▼ −1.25% −1.33% vs SPY
- Apr 30, 202628w ago Insider Cluster Neutral 4/10 Entry $60.96 to $63.40 Now $82.96 +36.09% ▲ +4.00% +1.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers